Juliane S. Falcão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juliane S. Falcão has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Guilherme S. Caleffi
Laboratório de Química Bioorgânica (LQB), Instituto de Pesquisa de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil
2 shared publications - Paulo Roberto Ribeiro Costa
Laboratório de Química Bioorgânica (LQB), Instituto de Pesquisa de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil
2 shared publications - Claudia Pessoa
Universidade Federal do Ceará, Brasil
1 shared publication - Edivaldo S. Dos Santos Rodrigues
Laboratório de Modelagem Molecular e Biologia Estrutural Computacional, Instituto de Pesquisas de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil
1 shared publication - José de Brito Vieira Neto
Núcleo de Pesquisa e Desenvolvimento de Medicamentos (NPDM), Federal University of Ceará (UFC), Fortaleza 60430-275, Brazil
1 shared publication - Marcos V. O. da Silva
Laboratório de Química Bioorgânica (LQB), Instituto de Pesquisa de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Concise Enantioselective Synthesis of the Antimitotic (+)-2,3,9-Trimethoxypterocarpan via Asymmetric Transfer Hydrogenation
(+)-2,3,9-Trimethoxypterocarpan [(+)-PTC] is a naturally occurring isoflavonoid that exhibits potent antitumor activity, putatively acting through the inhibition of kinesin-5 (Eg5), a mechanism distinct from classic tubulin-targeting agents. However, its preclinical development has been severely hampered by supply limitations, as previous synthetic routes relied on inefficient racemic strategies requiring laborious chiral resolution. Herein, we report a concise, biomimetic, and enantioselective total synthesis of (+)-PTC that overcomes these challenges. The route features a robust ligand-free Suzuki cross-coupling in PEG-400 and utilizes a ruthenium-catalyzed asymmetric transfer hydrogenation coupled with dynamic kinetic resolution (ATH-DKR) as the key stereodefining step. Optimized conditions enabled the scale-up of the key reduction with a low catalyst loading (2 mol%), delivering the pterocarpan core with high optical purity (98% ee) and excellent diastereocontrol. The synthesis was completed in just six steps with 64% overall yield, securing a sustainable supply of the bioactive enantiomer for advanced biological validation and providing divergent access to optically pure isoflavanone analogues.
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Concise Enantioselective Synthesis of the Antimitotic (+)-2,3,9-Trimethoxypterocarpan via Asymmetric Transfer Hydrogenation
(+)-2,3,9-Trimethoxypterocarpan [(+)-PTC] is a naturally occurring isoflavonoid that exhibits potent antitumor activity, putatively acting through the inhibition of kinesin-5 (Eg5), a mechanism distinct from classic tubulin-targeting agents. However, its preclinical development has been severely hampered by supply limitations, as previous synthetic routes relied on inefficient racemic strategies requiring laborious chiral resolution. Herein, we report a concise, biomimetic, and enantioselective total synthesis of (+)-PTC that overcomes these challenges. The route features a robust ligand-free Suzuki cross-coupling in PEG-400 and utilizes a ruthenium-catalyzed asymmetric transfer hydrogenation coupled with dynamic kinetic resolution (ATH-DKR) as the key stereodefining step. Optimized conditions enabled the scale-up of the key reduction with a low catalyst loading (2 mol%), delivering the pterocarpan core with high optical purity (98% ee) and excellent diastereocontrol. The synthesis was completed in just six steps with 64% overall yield, securing a sustainable supply of the bioactive enantiomer for advanced biological validation and providing divergent access to optically pure isoflavanone analogues.
- 23 December 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (4) , 1159-1174
Asymmetric transfer hydrogenation of polyoxygenated 3-arylidenechroman-4-ones: a powerful tool for the total synthesis of natural homoisoflavonoids
A mild and highly efficient one-pot asymmetric transfer hydrogenation (ATH) of challenging, electron-rich 3-arylidenechroman-4-ones is reported.
- 23 December 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (4) , 1159-1174
Asymmetric transfer hydrogenation of polyoxygenated 3-arylidenechroman-4-ones: a powerful tool for the total synthesis of natural homoisoflavonoids
A mild and highly efficient one-pot asymmetric transfer hydrogenation (ATH) of challenging, electron-rich 3-arylidenechroman-4-ones is reported.